Headquarters: Petach Tikva, Israel
Investor Relations: Bob Yedid / 646-597-6989 / Bob@LifeSciAdvisors.com

Description
A Phase 3 biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary PLEX technology,
Industry
Life Sciences
Year Founded
Website
Ownership
Public
Exchange / Symbol
NASDAQ: PUPD